Merit Financial Group, LLC

Position in BHC — Bausch Health Companies Inc.

CIK 1621225 ALPHARETTA, GA

Position in BHC

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$154,308

-$12,632 QoQ

Shares Held

31,300

+1.2% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#135

of 220 holders

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Merit Financial Group, LLC holds $14,160,724 across 17 Drug Manufacturers - Specialty & Generic names. BHC ranks #13 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	9,856	$5,340,273
2	NBIX	Neurocrine Biosciences Inc	18,744	$3,159,110
3	VTRS	Viatris Inc	74,483	$1,182,785
4	ZTS	Zoetis Inc.	13,254	$952,428
5	HLN	Haleon plc	101,892	$950,650
6	TAK	Takeda Pharmaceutical Co Ltd	35,173	$563,820
7	LNTH	Lantheus Holdings, Inc.	4,251	$471,603
8	KNSA	Kiniksa Pharmaceuticals International, plc	5,474	$350,060

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$154,308	31,300	+1.2%	Shares	Other	2026-07-20
2026-03-31	$166,940	30,915	-13.0%	Shares	Other	2026-04-15
2025-12-31	$246,981	35,537	+2.5%	Shares	Other	2026-01-26
2025-09-30	$223,640	34,673	+0.3%	Shares	Other	2025-11-07
2025-06-30	$230,296	34,579	+22.7%	Shares	Sole	2025-07-22
2025-03-31	$182,324	28,180	-0.2%	Shares	Sole	2025-04-09
2024-12-31	$227,654	28,245	+0.1%	Shares	Sole	2025-01-15
2024-06-30	$196,581	28,204	0.0%	Shares	Sole	2024-08-13
2024-03-31	$299,244	28,204	0.0%	Shares	Sole	2024-05-06
2023-12-31	$226,196	28,204	0.0%	Shares	Sole	2024-02-06
2023-09-30	$231,836	28,204	0.0%	Shares	Sole	2023-11-07
2023-06-30	$225,632	28,204	+9.4%	Shares	Sole	2023-08-01
2023-03-31	$208,753	25,772	+4.8%	Shares	Sole	2023-04-24
2022-12-31	$154,425	24,590	-16.9%	Shares	Sole	2023-01-13
2022-09-30	$203,875	29,590	—	Shares	Sole	2022-10-31
No filing history on record for this holder in this stock.